Scientific Program Committee
Scientific Program Committee
Scientific Program Committee
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CROI 2008 Session 55<br />
b Tuesday, 1-4 pm; Hall D<br />
Session 52–Poster Abstracts<br />
Viral Fitness, Evolution and Recombination<br />
253 Molecular Characterization of SIV in Wild Gorillas<br />
gor<br />
Jun Takehisa* 1 , M Kraus1 , Y Li1 , R Rudicell1 , B Keele1 , J Decker1 ,<br />
E Bailes2 , P Sharp3 , M Peeters4 , and B Hahn1 1 2 3 Univ of Alabama at Birmingham, US; Univ of Nottingham, UK; Univ of<br />
Edinburgh, Scotland; and 4Univ of Montpellier, France<br />
254 Generation of in vivo Intersubtype BG Recombinants<br />
of HIV-1 and Analysis of Intersubtype Breakpoints:<br />
Comparison to BG Recombinants Generated in vivo<br />
Mercedes Munoz-Nieto* 1 , L Perez-Alvarez1 , M Pinilla1 , Y Vega1 ,<br />
E Delgado1 , V Garcia1 , M Sierra1 , M Thomson1 , C Miralles2 , and<br />
R Najera1 1 2 Inst Salud Carlos III, Madrid, Spain and Hosp Xeral-Cies, Vigo,<br />
Pontevedra, Spain<br />
255 Immune-driven HIV-1 Recombination and Loss of Control<br />
following Superinfection<br />
Hendrik Streeck* 1 , B Li1 , A Poon2 , A Schneidewind1 , A Gladden1 ,<br />
K Power1 , B Walker1 , M Altfeld1 , S Frost2 , and T Allen1 1Partners AIDS Res Ctr, Massachusetts Gen Hosp, Harvard Med Sch,<br />
Boston, US and 2Univ of California, San Diego, US<br />
256 Identifying the Important HIV-1 Recombination Breakpoints<br />
John Archer* 1 , J Pinney1 , J Fan1 , E Simon-Loriere2 , E Arts3 ,<br />
M Negroni2 , and D Robertson1 1 2 3 Univ of Manchester, UK; Pasteur Inst, Paris, France; and Case<br />
Western Reserve Univ, Cleveland, OH, US<br />
257 Molecular Characterization of Recombinant CCR5- and<br />
CXCR4-utilizing HIV-1 Subtype C gp120<br />
Katherine Michler*, W Stevens, M Papathanasopoulos, and<br />
A Capovilla<br />
Univ of the Witwatersrand Med Sch, Johannesburg, South Africa<br />
258 A New Algorithm to Detect HIV-1 Intra-patient Recombinant<br />
Sequences and Investigate the Role of Recombination in the<br />
Emergence of CXCR4-using Viral Variants<br />
M Salemi1 , R Gray1 , J Sleasman2 , S Koch1 , and Maureen Goodenow* 1<br />
1 2 Univ of Florida, Gainsville, US and Univ of South Florida, St<br />
Petersburg, US<br />
259 Meta-evolutionary Analysis of Selection on HIV and Other<br />
Viruses: Functional and Subtype Correlates<br />
Sergei Kosakovsky Pond* 1 , C Woelk1 , A Poon1 , S Pillai2,3 , D Richman1,4 ,<br />
and S Frost1 1 2 Univ of California, San Diego, US; Univ of California, San Francisco,<br />
US; 3VAMC, San Francisco, CA, US; and 4VA San Diego Hlthcare<br />
System, La Jolla, CA, US<br />
260 Analysis of HIV-1 CA Residues under Positive Selective<br />
Pressure<br />
Angela Ciuffi*, K Zhang, M Munoz, R Martinez, and A Telenti<br />
Inst of Microbio, Univ Hosp Ctr and Univ of Lausanne, Switzerland<br />
261 Models of Neutralization and Sequence Variation in HIV-1<br />
Selene Zarate* 1 , D Richman2,3 , J Overbaugh4,5 , and S Frost2 1 2 Univ Autonoma de la Ciudad de Mexico, Mexico City; Univ of<br />
California, San Diego, US; 3VA Hlthcare System, San Diego, CA,<br />
US; 4Fred Hutchinson Cancer Res Ctr, Seattle, WA, US; and 5Univ of<br />
Washington, Seattle, US<br />
262 Construction of Replication-competent Chimeric HIV-1<br />
Reporter Viruses to Study Fitness Costs of Mutations in Non-<br />
Clade B Contexts<br />
Markus Bickel*, M Lewis, A Ali, and O Yang<br />
Univ of California, Los Angeles, US<br />
263 Differential Evolution of HIV-1 Reverse Transcriptase in<br />
Treatment-naïve Female Genital Tract and Plasma<br />
Uma Shanmugasundaram*, N Kumarasamy, K Murugavel, S Solomon,<br />
and P Balakrishnan<br />
YRGCARE, Voluntary Hlth Svcs, Chennai, India<br />
b Wednesday, 1-4 pm; Hall D<br />
Session 53–Poster Abstracts<br />
HIV-1 Macrophage Studies<br />
264 Visualization of HIV-1 Gag Trafficking to the Virological<br />
Synapse in Living Infected Macrophages<br />
K Gousset1 , S Ablan1 , L Coren2 , D Ott2 , and Eric Freed* 1<br />
1 2 HIV Drug Resistance Prgm, NCI-Frederick, MD, US and SAIC-<br />
Frederick and NCI-Frederick, MD, US<br />
265 Galectin-1 Increases Transfer of HIV-1 from Macrophages to<br />
CD4 + T Cells<br />
Simon Mercier*, C St-Pierre, M Ouellet, M Tremblay, and S Sato<br />
Laval Univ, Canada<br />
266 Links between Cellular Factors Expressed during Monocyte<br />
Differentiation and Productive HIV-1 Replication<br />
Irena Kadiu* 1 , T Wang1 , M Ricardo-Dukelow2 , J Schlautman1 ,<br />
P Ciborowski1 , and H Gendelman1 1 2 Univ of Nebraska Med Ctr, Omaha, US and Univ of Hawaii at Manoa,<br />
Honolulu, US<br />
267 HIV-1 Replication Is Enhanced by Macrophage Migration<br />
Inhibitory Factor<br />
Eduardo Regis* 1 , V Barreto-de-Souza1 , L Leng2 , R Bucala2 , M Bozza3 ,<br />
and D Bou-Habib1 1 2 Oswaldo Cruz Inst, Fiocruz, Rio de Janeiro, Brazil; Yale Univ Sch of<br />
Med, New Haven, CT, US; and 3Federal Univ of Rio de Janeiro, Brazil<br />
268 Entry Co-receptor Use and Fusion Inhibitor T20 Sensitivity<br />
of Dual-tropic R5X4 HIV-1 in Primary Macrophage<br />
Infection<br />
Yanjie Yi*, L Loftin, L Wang, S Ratcliffe, J Issacman-Beck, and<br />
R Collman<br />
Univ of Pennsylvania Sch of Med, Philadelphia, US<br />
b Wednesday, 1-4 pm; Hall D<br />
Session 54–Poster Abstracts<br />
Co-infection: Virus/Virus Interactions<br />
269 HIV Post-entry Inhibition by Non-structural GBV-C Proteins<br />
Susan Jung*, R Muller, N Donhauser, B Fleckenstein, and H Reil<br />
Univ Hosp, Erlangen, Germany<br />
270 E2, a Novel and Potent HIV Entry Inhibitor Derived from the<br />
Non-pathogenic GBV-C—Characterization of the Detailed<br />
Mechanism<br />
Kristin Hanel*, S Jung, B Fleckenstein, and H Reil<br />
Univ Hosp Erlangen, Germany<br />
271 Establishment of a Cord Blood Lymphocytes-based Cell<br />
Culture System to Study GBV-C and HIV in vitro<br />
Susan Jung*, S Weber, B Fleckenstein, and H Reil<br />
Univ Hosp Erlangen, Germany<br />
272 Interference between HSV-2 and HIV-1 in Co-infected<br />
Human Lymphoid Tissue ex vivo<br />
Christophe Vanpouille*, A Lisco, JC Grivel, A Biancotto,<br />
B Brichacek, and L Margolis<br />
NIH, Bethesda, MD, US<br />
273 GBV-C Infection Is Associated with Less T Cell Activation<br />
in Recently HIV-1-infected Subjects and Is Independent of<br />
HIV-1 Viral Load<br />
Maria Teresa Maidana Giret* 1 , T Silva1 , E Levi2 , H Tomiyama1 ,<br />
K Bassichetto3 , A Nishiya4 , E Sabino4 , R Palacios1 , and E Kallas1 1 2 Federal Univ of Sao Paulo, Brazil; Inst of Tropical Diseases of Sao<br />
Paulo, Brazil; 3Publ Hlth Dept of Sao Paulo, Brazil; and 4Blood Ctr of<br />
Sao Paulo, Brazil<br />
b Wednesday, 1-4 pm; Hall D<br />
Session 55–Poster Abstracts<br />
Viral Reservoirs<br />
274 Phylodynamic Analysis of SIV Populations in Lymphoid<br />
Tissues Reveals the Central Role of the Gut-associated<br />
Lymphoid Tissue as a Reservoir during Suppressive ART<br />
Thomas Ndolo* 1 , M Syvanen1 , J Pan1 , D Verhoeven1 , C Bedford2 ,<br />
R Donovan2 , and S Dandekar1 1 2 Univ of California, Davis, US and California Dept of Hlth Svcs,<br />
Richmond, US<br />
275 HIV-1 Transmission from Infected Dendritic Cells and<br />
Infection of Primary CD4 + T Lymphocytes in the Presence of<br />
Entry Inhibitors Targeting Co-receptors or gp41<br />
Jose Este* 1,2 , I Clotet1 , B Bosch1 , M Fernandez-Figueras2 , R Pena1 ,<br />
M Bofill1 , and B Clotet1,2 1 2 Fndn irsiCaixa, Spain and Hosp Germans Trials i Pujol, Badalona, Spain<br />
276 Different Activation Stimuli Induce Differential<br />
Sequestration of HIV-1 in Human Dendritic Cells<br />
Morgan Reuter*, H Yu, and D McDonald<br />
Case Western Reserve Univ, Cleveland, OH, US<br />
277 A Novel Model for the Establishment of HIV Latency<br />
in Primary CD4 + Cells Demonstrates Epigenetic<br />
Transcriptional Shutdown Due to Chromatin Restrictions<br />
Mudit Tyagi* and J Karn<br />
Case Western Reserve Univ Sch of Med, Cleveland, OH, US<br />
278 CCL2 Enhances Permissiveness of Resting CD4 + T Cells to<br />
Infection with X4-tropic HIV-1<br />
Grant Campbell* and S Spector<br />
Univ of California, San Diego, US<br />
279 HIV-1 Tat Association with Cellular Promoters in Human<br />
Immature Dendritic Cells<br />
Nayoung Kim*, S Kukkonen, and A Aldovini<br />
Children’s Hosp Boston, MA, US<br />
<strong>Program</strong> 27<br />
Poster Listings